Firm record

Avantor, Inc.

◇Private·—·GICS Pharmaceuticals, Biotechnology and Life Sciences

This is a partial record assembled from open public datasets (WBA, Net Zero Tracker, SBTi, TPI, CDP). Reverberate's deeper extraction layer covers a curated cohort of firms — see the full directory for firms with verified financial + multi-year disclosure depth.

Partial profile

We haven't fully researched Avantor, Inc. yet.

Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.

We’ll only use your email to notify you about this request.

Targets & commitments4

Source	Type	Scope	Base	Target year	Value	Status
sbti	near_term	3	2020	2030	25%	—
sbti	near_term	Scope 1 + 2	2020	2030	50%	1.5°C
sbti	—	—	—	—	—	—
sbti	near_term	3	2020	2030	42%	—

Identifiers

isin	US05352A1007
sbti_id	40009565
Reverberate ID	d27bb3e5…